Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis [Phase 3]
Phase 3 clinical trial protocol evaluating icotrokinra therapy for moderately to severely active ulcerative colitis in adults and adolescent…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study to Generate Real-world Evidence of Guselkumab Effectiveness in Inflammatory Bowel Disease in Germany
This clinical trial aims to generate real-world evidence on the effectiveness of guselkumab in treating inflammatory bowel disease, includin…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Describing Treatment Patterns and Creating an Updated Treatment Flow in an Ulcerative Colitis Population
This clinical trial update describes treatment patterns and an updated treatment flow for ulcerative colitis, focusing on study design rathe…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease
This is a multicenter, long-term observational registry enrolling pediatric patients with inflammatory bowel disease to collect real-world d…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's Disease in the United Kingdom (UK)
A UK real-world evidence study is evaluating guselkumab treatment for ulcerative colitis and Crohn's disease and is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis [Phase 2]
A Phase 2 clinical trial update indicates GS-1427 is being studied for moderately to severely active ulcerative colitis and is currently not…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Microbiome-targeted Diet Therapy in Ulcerative Colitis [NA]
A University of Minnesota-sponsored clinical trial is evaluating a microbiome-targeted dietary therapy for ulcerative colitis. The study is …
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Utility of Random Biopsies in Patients With Inflammatory Bowel Disease [NA]
Clinical trial update describing enrollment status for a study evaluating the utility of random biopsies in patients with inflammatory bowel…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Therapeutic Endpoint in Pediatric IBD Conditions
A pediatric inflammatory bowel disease trial from Children's National Research Institute is currently recruiting to evaluate a new therapeut…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis [Phase 2, Phase 3]
Ongoing Phase 2/Phase 3 clinical trial evaluating oral ozanimod in pediatric patients with moderate to severe active ulcerative colitis, cur…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Immune Regulation in Ulcerative Colitis or Crohn s Disease
A ClinicalTrials.gov listing for a study on immune regulation in ulcerative colitis and Crohn's disease, currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants
A clinical trial evaluating Jyseleca (filgotinib) in Korean participants for rheumatoid arthritis and ulcerative colitis is currently recrui…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A First-time in Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Target Engagement of GSK4528287 in Healthy Participants [Phase 1]
This first-in-human Phase 1 study from GlaxoSmithKline is evaluating safety, tolerability, pharmacokinetics and target engagement of GSK4528…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC) [Phase 2]
Phase 2 proof-of-concept study evaluating ATH-063 for efficacy and safety in relapsed/refractory moderately to severely active ulcerative co…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis [Phase 2]
This update reports a Phase 2 clinical trial evaluating the efficacy and safety of SAR441566 in patients with Ulcerative colitis, currently …
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: STOP-UC: De-escalation of Therapy in Patients With Ulcerative Colitis With Histological Remission [NA]
Clinical trial STOP-UC is evaluating de-escalation of therapy in patients with ulcerative colitis who are in histological remission; the stu…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis [Phase 3]
A Phase 3 clinical trial to evaluate the efficacy and safety of Duvakitug in participants with moderately to severely active ulcerative coli…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC) [Phase 2]
Phase 2 clinical trial evaluating the efficacy, safety, and pharmacokinetics of RO7837195 in participants with moderately to severely active…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis [Phase 3]
A phase 3 trial to assess efficacy and safety of Afimkibart (RO7790121) in moderately to severely active ulcerative colitis; recruitment is …
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: The Purpose of This Study is to Evaluate the Efficacy and Safety of 627 in the Treatment of UC [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety of 627 for Ulcerative Colitis; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Study Evaluating ISM5411 Administered Orally to Subjects With Active Ulcerative Colitis (BETHESDA) [Phase 2]
A Phase 2 clinical trial evaluating oral ISM5411 for active ulcerative colitis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis [Phase 2]
Pfizer is conducting a Phase 2 trial to evaluate etrasimod in adolescents with ulcerative colitis, and the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Aquamin® for Prevention of Ulcerative Colitis J-Pouch-associate Intestinal Inflammation [Phase 2]
Phase 2 trial evaluating Aquamin for prevention of J-pouch-associated intestinal inflammation in ulcerative colitis patients. The study stat…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis [Phase 3]
Pfizer is conducting a Phase 3 extension study for the treatment of moderately to severely active ulcerative colitis; the trial is currently…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Tailored Anti-Inflammatory (A-I) Diet for Americans With Ulcerative Colitis (UC) [NA]
Sponsored by the University of Miami, this clinical trial is evaluating a tailored anti-inflammatory diet for ulcerative colitis and is curr…